project id: TCGA-BRCA; case submitter id: TCGA-3C-AAAU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.2; rna integrity number: 9.8; age at index: 55; days to birth: -20211; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 20211; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage X; ajcc pathologic t: TX; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4047.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 3599; initial weight: 60.0; sample id: 197b76a1-a09a-4659-83aa-2c14fd1023a9; sample submitter id: TCGA-3C-AAAU-01A; portion id: 4d933452-4563-4dbd-b0a3-8f0a5a93b51c; portion submitter id: TCGA-3C-AAAU-01A-11; slide id: 2f52dd63-7476-4e85-b7c6-e06092db6cc1; slide submitter id: TCGA-3C-AAAU-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;